Should I buy or sell XWELL stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for XWELL in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" XWEL shares. View XWEL analyst ratings or view top-rated stocks .

What is XWELL's stock price target for 2024?

1 brokerages have issued twelve-month target prices for XWELL's stock. Their XWEL share price targets range from $7.00 to $7.00. On average, they expect the company's stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 407.2% from the stock's current price. View analysts price targets for XWEL or view top-rated stocks among Wall Street analysts .

How have XWEL shares performed in 2024?

XWELL's stock was trading at $1.74 at the beginning of the year. Since then, XWEL shares have decreased by 20.7% and is now trading at $1.38. View the best growth stocks for 2024 here .

Are investors shorting XWELL?

XWELL saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 68,300 shares, an increase of 23.3% from the March 15th total of 55,400 shares. Based on an average daily volume of 12,500 shares, the short-interest ratio is currently 5.5 days. Approximately 1.7% of the shares of the company are short sold. View XWELL's Short Interest .

When is XWELL's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our XWEL earnings forecast .

When did XWELL's stock split?

XWELL's stock reverse split before market open on Thursday, September 28th 2023. The 1-20 reverse split was announced on Thursday, September 28th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of XWELL?

Shares of XWEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:XWEL

XWELL (XWEL) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free XWEL Stock Alerts

$1.38

-0.02 (-1.43%)

(As of 04/19/2024 ET)

Compare

Today's Range: $1.32
▼
$1.45
50-Day Range: $1.37
▼
$2.15
52-Week Range: $1.26
▼
$6.40

Volume: 4,414 shs
Average Volume: 12,086 shs
Market Capitalization: $5.77 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $7.00

Get XWELL alerts:

XWELL MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 407.2% Upside
$7.00 Price Target
Short Interest: Bearish
1.68% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.50
Based on 8 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.36 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
XWELL has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
XWELL has received no research coverage in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
1.68% of the float of XWELL has been sold short.
Short Interest Ratio / Days to Cover
XWELL has a short interest ratio ("days to cover") of 5.5.
Change versus previous month
Short interest in XWELL has recently increased by 23.29%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
XWELL does not currently pay a dividend.
Dividend Growth
XWELL does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for XWEL.

2.5

News and Social Media Coverage

News Sentiment
XWELL has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 8 news articles for XWELL this week, compared to 1 article on an average week.
Search Interest
4 people have searched for XWEL on MarketBeat in the last 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, XWELL insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 4.90% of the stock of XWELL is held by insiders.
Percentage Held by Institutions
Only 8.67% of the stock of XWELL is held by institutions.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of XWELL is -0.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of XWELL is -0.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
XWELL has a P/B Ratio of 0.14. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Behind the Markets

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

About XWELL Stock (NASDAQ:XWEL)

XWELL, Inc., a health and wellness services company, provides spa services at airports. It operates through XpresSpa, XpresTest, Treat, and HyperPointe segments. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also provides diagnostic COVID-19 tests at XpresCheck wellness centers in airports; and other medical diagnostic testing services. In addition, the company offers marketing support to health and health-related channels. It operates stores, as well as offers its services through an integrated digital platform, as well as operates Naples wax center's in the Naples and Cape Coral markets. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. was founded in 2006 and is headquartered in New York, New York.

XWEL Stock Price History

30 days | 90 days | 365 days | Advanced Chart

XWEL Stock News Headlines

April 19, 2024 | finance.yahoo.com

XWELL Inc (XWEL) Q4 2023 Earnings Call Transcript Highlights: Strategic Expansions and Cost ...

April 18, 2024 | investing.com

Earnings call: XWELL reports growth and expansion amid financial restatement

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

April 18, 2024 | seekingalpha.com

XWELL, Inc. (XWEL) Q4 2023 Earnings Call Transcript

April 17, 2024 | finance.yahoo.com

XWELL, Inc. (NASDAQ:XWEL) Q4 2023 Earnings Call Transcript

April 17, 2024 | investorplace.com

XWEL Stock Earnings: XWELL Misses EPS, Misses Revenue for Q4 2023

April 16, 2024 | finance.yahoo.com

XWELL, Inc. Reports Fiscal Year 2023 Results

April 16, 2024 | globenewswire.com

XWELL, Inc. to Report Fiscal Year 2023 Financial Results on Tuesday, April 16, 2024

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

April 13, 2024 | americanbankingnews.com

XWELL, Inc. (NASDAQ:XWEL) Short Interest Up 23.3% in March

April 1, 2024 | finance.yahoo.com

XWELL, Inc. Plans to File Form 12b-25 to Extend Filing Date of its Form 10-K

April 1, 2024 | globenewswire.com

XWELL, Inc. Plans to File Form 12b-25 to Extend Filing Date of its Form 10-K

March 16, 2024 | finance.yahoo.com

DNA Apr 2024 0.500 put

March 15, 2024 | finance.yahoo.com

DNA May 2024 1.500 put

March 12, 2024 | msn.com

US airport nasal swabbing expanding to Chicago and Miami

March 12, 2024 | msn.com

U.S. airport nasal swabbing expanding to Chicago and Miami

March 12, 2024 | prnewswire.com

CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago

February 22, 2024 | benzinga.com

XWELL Stock (NASDAQ:XWEL) Dividends: History, Yield and Dates

February 14, 2024 | finance.yahoo.com

XWELL Advances Expansion Plan Outside the Airport with Three New Naples Wax and Skin Care Locations

January 5, 2024 | bizjournals.com

XpresSpa targets New York City's Penn Station for expansion beyond airports

January 4, 2024 | finance.yahoo.com

XWELL Announces Plans to Open an XpresSpa in THE PENN DISTRICT

December 15, 2023 | finance.yahoo.com

XWELL Appoints Veteran Consumer & Wellness Entrepreneur Gaëlle Wizenberg to its Board of Directors

December 11, 2023 | finance.yahoo.com

XpresSpa Introduces Clockwork Robotic Manicures at Harry Reid International Airport in Las Vegas

November 16, 2023 | marketwatch.com

XWELL Inc.

November 16, 2023 | uk.finance.yahoo.com

XWELL, Inc. (XWEL) stock price, news, quote & history – Yahoo Finance

November 16, 2023 | msn.com

XWELL, Xeris Biopharma among healthcare movers

November 15, 2023 | finance.yahoo.com

XWELL Opens New XpresSpa Location in Abu Dhabi International Airport

See More Headlines

Receive XWEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for XWELL and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Personal services
Sub-Industry: N/A
Current Symbol: NASDAQ:XWEL
CUSIP: N/A
CIK: 1410428
Web: www.xwell.com
Phone: (212) 750-9595
Fax: 309-410-3967
Employees: 382
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $7.00
High Stock Price Target: $7.00
Low Stock Price Target: $7.00
Potential Upside/Downside: +400.0%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($6.75)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-32,840,000.00
Net Margins: -114.37%
Pretax Margin: -117.95%
Return on Equity: -71.91%
Return on Assets: -47.54%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.67
Quick Ratio: 3.55

Sales & Book Value

Annual Sales: $30.11 million
Price / Sales: 0.19
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $10.17 per share
Price / Book: 0.14

Miscellaneous

Outstanding Shares: 4,180,000
Free Float: 3,975,000
Market Cap: $5.85 million
Optionable: Optionable
Beta: 2.43

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Scott R. Milford (Age 60)
President, CEO & Director
Comp: $595.17k
Mr. Ezra T. Ernst (Age 55)
Executive Vice President
Comp: $325.43k
Mr. Omar A. Haynes (Age 41)
VP of Treasury & Finance
Comp: $353.11k
Ms. Suzanne Scrabis (Age 54)
Chief Financial Officer
Mr. David Kohel
Chief Technology Officer
Ms. Cara Soffer
Senior VP & General Counsel
Pablo Henderson
Chief Marketing Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

XWEL Stock Analysis - Frequently Asked Questions

Should I buy or sell XWELL stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for XWELL in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" XWEL shares.
View XWEL analyst ratings or view top-rated stocks.
What is XWELL's stock price target for 2024?: 1 brokerages have issued twelve-month target prices for XWELL's stock. Their XWEL share price targets range from $7.00 to $7.00. On average, they expect the company's stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 407.2% from the stock's current price.
View analysts price targets for XWEL or view top-rated stocks among Wall Street analysts.
How have XWEL shares performed in 2024?: XWELL's stock was trading at $1.74 at the beginning of the year. Since then, XWEL shares have decreased by 20.7% and is now trading at $1.38.
View the best growth stocks for 2024 here.
Are investors shorting XWELL?: XWELL saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 68,300 shares, an increase of 23.3% from the March 15th total of 55,400 shares. Based on an average daily volume of 12,500 shares, the short-interest ratio is currently 5.5 days. Approximately 1.7% of the shares of the company are short sold.
View XWELL's Short Interest.

When is XWELL's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our XWEL earnings forecast.
When did XWELL's stock split?: XWELL's stock reverse split before market open on Thursday, September 28th 2023. The 1-20 reverse split was announced on Thursday, September 28th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.
How do I buy shares of XWELL?: Shares of XWEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:XWEL) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

XWELL (XWEL) Stock Price, News & Analysis

XWELL MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About XWELL Stock (NASDAQ:XWEL)

XWEL Stock Price History

XWEL Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

XWEL Stock Analysis - Frequently Asked Questions

Overall MarketRank^™